Business
LEVBIO: Flat sales but improved results and cash flow signal operational progress and future growth
LEVBIO: Flat sales but improved results and cash flow signal operational progress and future growth
About this update from Level Bio Ab
Net sales were flat year-over-year at 6,421 KSEK, but operating loss and cash flow improved significantly. Cost reductions, new distribution agreements, and a directed share issue support a positive outlook for growth and financial stability.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.